Scientists have used a new type of gene therapy to cure leukaemia patients. The treatment, which uses edited immune cells ...

A therapy that would once have been considered a feat of science fiction has reversed aggressive and incurable blood cancers ...

Professor Waseem Qasim told LBC News the breakthrough demonstrates "the power and the potential" of emerging technologies ...

Terns also expects to grant underwriters a 30-day option to buy up to an additional $60 million of shares. Later on Wednesday, Terns said it would price a separate public offering of 16.3 million ...

PVEK, a CD123-targeting antibody-drug conjugate, demonstrated strong response rates in two studies. Combined with VEN/AZA, it ...

MONTREAL, Dec. 10, 2025 /CNW/ - Novartis Canada is pleased to announce that Scemblix ® (asciminib) is one of the first therapies to be prioritized for public reimbursement under Ontario's new Funding ...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Alfred Olivares, global managing partner, healthcare & ...

Researchers from The University of Texas MD Anderson Cancer Center presented promising new data from two ongoing studies of ...

Pediatric cancer is rare, but if your child or someone you know gets sick, having the right kind of treatment is critical.

Researchers from The University of Texas MD Anderson Cancer Center presented promising new data from two ongoing studies of ...

Incyte ( INCY) on Sunday said the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to ...

The FDA has qualified the first AI-based tool that can be used in clinical trials involving patients with metabolic ...